UBS Group’s ENDRA Life Sciences NDRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.5K | Buy |
+4,695
| New | +$16.5K | ﹤0.01% | 7253 |
|
|
2025
Q1 | – | Sell |
-95
| Closed | -$595 | – | 9125 |
|
|
2024
Q4 | $595 | Buy |
+95
| New | +$595 | ﹤0.01% | 8169 |
|
|
2024
Q3 | – | Sell |
-32
| Closed | -$5.38K | – | 8597 |
|
|
2024
Q2 | $5.38K | Buy |
+32
| New | +$5.38K | ﹤0.01% | 6844 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 7694 |
|
|
2023
Q1 | – | Sell |
-1
| Closed | -$8.75K | – | 8824 |
|
|
2022
Q4 | $8.75K | Buy |
+1
| New | +$8.75K | ﹤0.01% | 7541 |
|
|
2022
Q3 | – | Sell |
-1
| Closed | -$9K | – | 9514 |
|
|
2022
Q2 | $9K | Hold |
1
| – | – | ﹤0.01% | 7116 |
|
|
2022
Q1 | $11K | Hold |
1
| – | – | ﹤0.01% | 7253 |
|
|
2021
Q4 | $19K | Hold |
1
| – | – | ﹤0.01% | 6791 |
|
|
2021
Q3 | $49K | Hold |
1
| – | – | ﹤0.01% | 5251 |
|
|
2021
Q2 | $64K | Hold |
1
| – | – | ﹤0.01% | 5158 |
|
|
2021
Q1 | $79K | Buy |
+1
| New | +$79K | ﹤0.01% | 5147 |
|
|
2020
Q4 | – | Hold |
0
| – | -$7K | – | 6807 |
|
|
2020
Q3 | – | Hold |
0
| – | -$1K | – | 6246 |
|
|
2020
Q2 | – | Hold |
0
| – | -$2K | – | 6919 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6695 |
|
|
2019
Q2 | – | Hold |
0
| – | -$3K | – | 7075 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 6504 |
|
|
2018
Q2 | – | Hold |
0
| – | -$6K | – | 7107 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 6262 |
|
|
2017
Q4 | – | Hold |
0
| – | -$12K | – | 6925 |
|
|
2017
Q3 | – | Hold |
0
| – | -$8K | – | 5875 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 5969 |
|